Express Healthcare
Home  »  Insurance  »  Digit Insurance introduces one cover for 8 viral diseases

Digit Insurance introduces one cover for 8 viral diseases

0 298
Read Article

Policy covers hospitalisation for COVID-19, dengue, malaria, filariasis, kala azar, chikungunya, Japanese encephalitis and the Zika virus

Under the Sandbox regulations which encourages insurance companies to launch innovative products, Digit Insurance’s latest offering under Digit’s Illness Group Insurance covers against COVID-19 and seven vector-borne diseases like dengue, malaria, filariasis (payable only once in a lifetime), kala azar, chikungunya, Japanese encephalitis and the Zika virus.

According to the WHO (World Health Organisation), vector-borne diseases account for 17 per cent of all infectious diseases and leads to 700,000 deaths every year, worldwide. Hence, insurance players are adding vector-borne diseases to their insurance policies.

Digit’s cover for COVID-19 and vector-borne disease policy apparently also covers pre-hospitalisation expenses for up to 30 days, post-hospitalisation expenses up to 60 days, road ambulance charges (1 per cent of chosen SI, up to Rs 5,000) and a second medical opinion. The product is currently available on Digit’s website and offers options of choosing sum insured of Rs1 lakh, Rs 2 lakh or Rs 3 lakh.

As per a release, the policy can be bought for self, spouse and kids, with no capping of room rent, allowing the insured to choose the room they want. The cover offers no limit on room rent or ICU room rent.

Customers can reportedly choose from the three sum insured options based on personal requirements. The cover has a minimum waiting period of 15 days from the date of the start of the policy. The process of buying this health insurance policy and making claims is made simple online.

The product’s COVID-related claims cover the insured if they are an inpatient and hospitalisation was solely due to COVID-19 during the policy period.

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More